Pneumococcal vaccination in Europe – the current situation
3 Jun, 2026
Pneumococcal vaccination in Europe
While improvements have been made in pneumococcal vaccination across Europe, too many people are still being left behind.
Since 2021, pneumococcal vaccination coverage has risen by over seven percentage points for older adults and by almost ten points for at-risk groups. Six additional countries now recommend pneumococcal vaccination for older adults, and not a single country has withdrawn that recommendation. Four more countries fund it too.
Despite more countries now recommending and funding vaccination than during the first wave of our Pneumococcal Vaccination Atlas, stark gaps remain in coverage data for adults.
- Coverage still averages just 35–37% in adult and at-risk groups, compared to 88.9% in infants.
- Coverage data for at-risk groups are available for only 11 of 42 countries, and for older adults for just 15 of 42.
- Funding has expanded in some countries but contracted in others.
Infant vaccination shows what is possible when policy and funding align: 40 countries recommend it, 40 fund it, and average coverage sits at 88.9% across 38 countries. For older adults and at-risk groups, Europe still falls well short of this.
Our latest comparison report sets out the policy opportunities for European countries to close the funding gap and boost pneumococcal vaccination coverage.

